Catalent Inc Quick Ratio (CTLT) starting from the first quarter 2025 to first quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Catalent Inc   (NYSE: CTLT)

Catalent Inc 's Quick Ratio

CTLT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




Within Major Pharmaceutical Preparations industry Catalent Inc booked the highest Quick Ratio than Catalent Inc in the first quarter 2025. While total ranking remained the same in the Q1 2025 compared to the first quarter 2024 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents CTLT´s has?
What are CTLT´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CTLT/financial-strength
https://api.csimarket.com/api/v1/companies/CTLT/fundamentals
https://api.csimarket.com/api/v1/companies/CTLT/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
CTLT Quick Ratio (Jun 30 2025)
Q1
(Sep 30 2024)
Q4
(Jun 30 2024)
Q3
(Mar 31 2024)
Q2
(Dec 31 2023)
Q1
Y / Y Current Liabilities Change -37.64 %
Y / Y Cash & cash equivalent Change -
Quick Ratio MRQ -
CTLT's Total Ranking #
Seq. Current Liabilities Change -35.27 %
Seq. Cash & cash equivalent Change -



Quick Ratio first quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Catalent Inc 's Current Liabilities $ 646 Millions Visit CTLT's Balance sheet
Catalent Inc 's Cash & cash equivalent $ 0 Millions Visit CTLT's Balance sheet
Source of CTLT's Sales Visit CTLT's Sales by Geography


Cumulative Catalent Inc 's Quick Ratio

CTLT's Quick Ratio for the trailling 12 Months

CTLT Quick Ratio

(Jun 30 2025)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth -37.09 %
Y / Y Cash & cash equivalent TTM Growth -18.97 %
Quick Ratio TTM 0.24
Total Ranking TTM # 2469
Seq. Current Liabilities TTM Growth -10.69 %
Seq. Cash & cash equivalent TTM Growth -22.56 %


On the trailing twelve months basis In spite of the year on year decrease in CTLT's Current Liabilities to $646.00 millions, cumulative Quick Ratio to 0.24 below the CTLT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 479 other companies have achieved higher Quick Ratio than Catalent Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2024 at 3465.

Explain Quick Ratio?
How much Cash & cash equivalents CTLT´s has?
What are CTLT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 480
Healthcare Sector # 985
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
1.05 0.54 0.17
(Sep 30 2021)   (Mar 31 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2025, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2025 MRQ Cash & cash equivalentJun 30 2025 MRQ Current Liabilities

Date modified: 2026-09-26T06:52:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.